Oculis Holding AG (OCS) Return on Capital Employed [ROCE] (2023 - 2026)
Oculis Holding AG (OCS) recorded Return on Capital Employed [ROCE] of 0.53% in Q2 2026, up 0.04 percentage points from 0.49% a year earlier but down 0.04 percentage points from the prior quarter.
Oculis Holding AG (OCS) Return on Capital Employed [ROCE] (2023 - 2026) Analysis & Trends
For FY2025, Oculis Holding AG reported Return on Capital Employed [ROCE] of 0.88%, up 0.48 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has a three-year change of -1.60 percentage points (FY2022 to FY2025).
- Across earlier years, Return on Capital Employed [ROCE] came in at 0.41% in FY2024 (-0.17 pp), 0.58% in FY2023 (-1.90 pp) and 2.48% in FY2022.
- Quarterly Return on Capital Employed [ROCE] has ranged from 0.43% in Q4 2023 to 0.92% in Q2 2024 over the past five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] rose in four of the last eight quarters, with an average year-over-year change of -0.04 percentage points.
- Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 0.42 percentage points in Q4 2024, against a drop of 0.42 percentage points in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 0.57% (Q1 2026), 0.70% (Q4 2025) and 0.54% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Oculis Holding AG | 456.08 Mn | 456.08 Mn | - | 0.53% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.53% |
| Mar 31, 2026 | 0.57% |
| Dec 31, 2025 | 0.70% |
| Sep 30, 2025 | 0.54% |
| Jun 30, 2025 | 0.49% |
| Mar 31, 2025 | 0.61% |
| Dec 31, 2024 | 0.86% |
| Sep 30, 2024 | 0.84% |
| Jun 30, 2024 | 0.92% |
| Mar 31, 2024 | 0.47% |
| Dec 31, 2023 | 0.43% |
| Sep 30, 2023 | 0.81% |
Oculis Holding AG Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OCS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "OCS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OCS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();